JAZZ - Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q4 2021 Results - Earnings Call Transcript
Jazz Pharmaceuticals plc (JAZZ) Q4 2021 Earnings Conference Call March 1, 2022 4:30 PM ET Company Participants Andrea Flynn - VP & Head, IR Bruce Cozadd - Co-Founder, Chairman & CEO Daniel Swisher - President Robert Iannone - EVP, Research & Development & Chief Medical Officer Renée Galá - EVP & CFO Kim Sablich - EVP & GM, North America Conference Call Participants Kenneth Cacciatore - Cowen and Company Jessica Fye - JPMorgan Akash Tewari - Jefferies Marc Goodman - SVB Leerink Jason Gerberry - BofA Securities Ami Fadia - Needham & Company Aaron Gal - Sanford C. Bernstein Balaji Prasad - Barclays Annabel Samimy - Stifel Gary Nachman - BMO Capital Markets David Amsellem - Piper Sandler Navann Ty - Citigroup Inc. Gregory Fraser - Truist Securities Presentation Operator Good day, and welcome to the Fourth Quarter 2021 Jazz Pharmaceuticals Earnings Conference Call. At this time, all participants are
For further details see:
Jazz Pharmaceuticals plc (JAZZ) CEO Bruce Cozadd on Q4 2021 Results - Earnings Call Transcript